search
Back to results

Hartmanns Procedure or Abdominoperineal Excision With Intersphincteric Dissection in Rectal Cancer: a Randomized Study (HAPIrect)

Primary Purpose

Rectal Cancer, Sphincter Ani Incontinence, Other Diagnoses, Comorbidities, and Complications

Status
Terminated
Phase
Not Applicable
Locations
Sweden
Study Type
Interventional
Intervention
APE with intersphincteric dissection
Hartmann´s procedure
Sponsored by
Region Västmanland
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Rectal Cancer focused on measuring rectal cancer,, fecal incontinence,, severe co-morbidity,, Hartmann´s procedure,, abdominoperineal excision with intersphincteric dissection,, postoperative complications,, pelvic abscess,, perineal infections

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Rectal cancer 5cm or more from the anal verge
  • Both procedures should be possible to perform
  • Patients should have co-morbidities and/or have weak anal sphincter where an anterior resection is not suitable
  • Metastases are no contraindication but the procedure should be assessed as locally radical.
  • Patients should be assesed to cope with a major abdominal procedure(ASA I-III)

Exclusion Criteria:

  • rectal cancer below 5cm from the anal verge where a Hartmann is considered not to be locally radical.
  • patients where an anterior resection is suitable
  • ASA IV or worse

Sites / Locations

  • Västmanlands Hospital Västerås

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

APE with intersphincteric dissection

Hartmann´s procedure

Arm Description

Abdominoperineal excision with intersphincteric dissection and a stoma is performed in patients with rectal cancer and fecal incontinence and/or severe co-morbidity

Hartmann´s operation and stoma is performed in patients with rectal cancer and fecal incontinence and/or severe co-morbidity

Outcomes

Primary Outcome Measures

Rates ot postoperative surgical complications within 30 days.
Perineal and abdominal wound infection, pelvic abscess urinary catheter at discharge etc

Secondary Outcome Measures

Peroperative data
time of surgery, bleeding in ml, peroperative complications, type of staplers used
The rate of intraoperative perforations
record perforation of rectum or tumour during surgery
Resection margins
Histopathological report
Rate of local recurrence
Record local recurrence during follow-up. CT-scan after 1 and 3 years
Survival after 3 and 5 years follow-up
overall survival
Postoperative actions
reoperation, interventions(percutaneous drains etc) hospital stay, rehospitalisation
Other postop complications
other infectious, cardio-pulmonary and thromb-embolic complications.

Full Information

First Posted
November 21, 2013
Last Updated
December 1, 2021
Sponsor
Region Västmanland
search

1. Study Identification

Unique Protocol Identification Number
NCT01995396
Brief Title
Hartmanns Procedure or Abdominoperineal Excision With Intersphincteric Dissection in Rectal Cancer: a Randomized Study
Acronym
HAPIrect
Official Title
Hartmanns Procedure or Abdominoperineal Excision With Intersphincteric Dissection in Rectal Cancer: a Randomized Study
Study Type
Interventional

2. Study Status

Record Verification Date
December 2021
Overall Recruitment Status
Terminated
Why Stopped
Decision after interims analysis
Study Start Date
February 2014 (undefined)
Primary Completion Date
December 2021 (Actual)
Study Completion Date
December 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Region Västmanland

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
In patients with rectal cancer, an anterior resection with a colo-rectal or colo-anal anastomoses is the gold standard. However, in patients with a weak sphincter and fecal incontinence or in patients with severe co-morbidity and reduced general condition, this operation is not suitable. In these situations there are two other radical surgical options, Hartmanns procedure and the Abdominoperineal excision that can be performed with intersphincteric dissection to minimise perineal complications.There are no data on which of these procedures that are best suited for these patients with fecal incontinence or severe co-morbidity( at risk for life-threatening anastomotic leak). In this randomized study we intend to compare postoperative complications within 30 days after these two procedures and also late complications and quality of life after one year postoperatively.
Detailed Description
In patients with rectal cancer, an abdominal operation with anterior resection with total mesorectal excision is the gold standard. Colon is anastomosed to the ano-rectum.The potential risks are bad bowel function with fecal incontinence or a lifethreatening anastomotic dehiscence, especially in patients with severe co-morbidity or reduced general condition.Tumours in the low rectum are usually treated with an abdominoperineal resection where the whole anus is radically excised and a permanent colostomy is created. For patients with incontinence and/or severe comorbidity, Hartmann´s procedure has often been performed. The rectum is resected, the lower part is transected with a stapler and a colostomy is created. During recent years there has been reports on high rates of pelvic abscesses after Hartmann´s. An alternative has been proposed, namely the abdominoperineal excision (APE) with intersphincteric dissection leaving the outer sphincter and levator muscles in place, thus creating a much lesser perineal wound that also tend to heal better when the ano-pelvic muscles are left in place. There have been some small retrospective studies comparing postoperative complications after Hartmann´s with anterior resections or the classic abdominoperineal excision. These studies are heterogenous and not balanced and no conclusions can be drawn. There are no data on APE with intersphincteric dissection in rectal cancer patients. There is a need to clarify what procedure is most suited for patients with rectal cancer and fecal incontinence and / or severe comorbidity. For this patient group we intend to randomize between Hartmann´s procedure and APE with intersphincteric dissection.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Rectal Cancer, Sphincter Ani Incontinence, Other Diagnoses, Comorbidities, and Complications
Keywords
rectal cancer,, fecal incontinence,, severe co-morbidity,, Hartmann´s procedure,, abdominoperineal excision with intersphincteric dissection,, postoperative complications,, pelvic abscess,, perineal infections

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
164 (Actual)

8. Arms, Groups, and Interventions

Arm Title
APE with intersphincteric dissection
Arm Type
Active Comparator
Arm Description
Abdominoperineal excision with intersphincteric dissection and a stoma is performed in patients with rectal cancer and fecal incontinence and/or severe co-morbidity
Arm Title
Hartmann´s procedure
Arm Type
Active Comparator
Arm Description
Hartmann´s operation and stoma is performed in patients with rectal cancer and fecal incontinence and/or severe co-morbidity
Intervention Type
Procedure
Intervention Name(s)
APE with intersphincteric dissection
Intervention Description
Abdominal operation where the rectum is resected down to the levator and then the anus is resected by an intersphincteric dissection and order to leave the outer sfincter and levator in place to avoid a large wound and a high rate of infectious complications.
Intervention Type
Procedure
Intervention Name(s)
Hartmann´s procedure
Intervention Description
Abdominal operation where the rectum is resected and stapled off distally and a stoma is created
Primary Outcome Measure Information:
Title
Rates ot postoperative surgical complications within 30 days.
Description
Perineal and abdominal wound infection, pelvic abscess urinary catheter at discharge etc
Time Frame
30 days
Secondary Outcome Measure Information:
Title
Peroperative data
Description
time of surgery, bleeding in ml, peroperative complications, type of staplers used
Time Frame
day of surgery
Title
The rate of intraoperative perforations
Description
record perforation of rectum or tumour during surgery
Time Frame
day of surgery
Title
Resection margins
Description
Histopathological report
Time Frame
2-4 weeks after surgery
Title
Rate of local recurrence
Description
Record local recurrence during follow-up. CT-scan after 1 and 3 years
Time Frame
3 and 5 years postoperatively
Title
Survival after 3 and 5 years follow-up
Description
overall survival
Time Frame
3 and 5 years postoperativelly
Title
Postoperative actions
Description
reoperation, interventions(percutaneous drains etc) hospital stay, rehospitalisation
Time Frame
within 30 days
Title
Other postop complications
Description
other infectious, cardio-pulmonary and thromb-embolic complications.
Time Frame
30 days
Other Pre-specified Outcome Measures:
Title
quality of life between the two methods
Description
QoL protocol according to the QoLiRECT-study (Quality of life rectal cancer study) a study running from Gothenburg, Sweden
Time Frame
Preoperative and one year after surgery
Title
Late complications after surgery
Description
Perineal pain, secretion from the ano-rectal stump
Time Frame
One year postoperativelly

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Rectal cancer 5cm or more from the anal verge Both procedures should be possible to perform Patients should have co-morbidities and/or have weak anal sphincter where an anterior resection is not suitable Metastases are no contraindication but the procedure should be assessed as locally radical. Patients should be assesed to cope with a major abdominal procedure(ASA I-III) Exclusion Criteria: rectal cancer below 5cm from the anal verge where a Hartmann is considered not to be locally radical. patients where an anterior resection is suitable ASA IV or worse
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Kenneth Smedh, PhD
Organizational Affiliation
Region Vastmanland
Official's Role
Principal Investigator
Facility Information:
Facility Name
Västmanlands Hospital Västerås
City
Västerås
ZIP/Postal Code
72189
Country
Sweden

12. IPD Sharing Statement

Citations:
PubMed Identifier
27401339
Citation
Smedh K, Sverrisson I, Chabok A, Nikberg M; HAPIrect Collaborative Study Group. Hartmann's procedure vs abdominoperineal resection with intersphincteric dissection in patients with rectal cancer: a randomized multicentre trial (HAPIrect). BMC Surg. 2016 Jul 11;16(1):43. doi: 10.1186/s12893-016-0161-2.
Results Reference
derived

Learn more about this trial

Hartmanns Procedure or Abdominoperineal Excision With Intersphincteric Dissection in Rectal Cancer: a Randomized Study

We'll reach out to this number within 24 hrs